IMMUNODIAGNOSTIC SYSTEMS HOLDINGS (AIM:IDH) – the expected excellent Interim Results
The AIM quoted producer of diagnostic testing kits for the clinical and research markets, announced high flying interim results for the six month period to 30 September 2010.
IDH operate in the in-vitro diagnostics (“IVD”) market and designs, manufactures and sells immunoassay kits. These are used to measure or detect particular substances within a sample, thus aiding the diagnosis or monitoring of a disease or providing information for research studies. In 2008 the company commented that the immunoassay sector of the IVD market was estimated to be worth US$14bn, a staggering number! Revenue for the half year was up 34% to £22.6m, pre-tax profit up 44% to £6.6m and earnings per share (diluted) up 54% to 18.8p. With full year forecast earnings per share 44.74p at the current…